Between 2012 and 2022, the Pharmaceuticals in Dosage market in the Philippines exhibited a general upward trend despite some fluctuations. From 2012 to 2022, market value increased from $2.8314 billion to $4.5376 billion. Notable year-on-year variations include a significant rise of 20.89% in 2015 and a 14.61% increase in 2021. However, the market saw dips, such as a 4.88% decrease in 2014 and a 7.23% decline in 2022. The Compound Annual Growth Rate (CAGR) over the last five years was modest, standing at 0.82% by 2022.
As of 2023, considering the previous year’s value, the market stood around $4.5376 billion with a mix of positive and negative annual variations shaping the landscape.
Future trends to watch for include the impact of technological advancements in pharmaceutical manufacturing, the adoption of telemedicine, increased healthcare spending, and potential regulatory changes. These factors could drive growth and market dynamics in the coming years.
How does the Philippines rank in Pharmaceuticals in Dosage Market Size Value?
| # | 59 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 110,040,000,000 | 2023 | -0.57% | +2.9% | View data |
| 2 | 2 Japan | 102,270,000,000 | 2023 | +1.29% | +1.27% | View data |
| 3 | 3 Italy | 90,420,000,000 | 2023 | -0.45% | +3.03% | View data |
| 4 | 4 France | 70,241,000,000 | 2023 | -2.11% | -1.64% | View data |
| 5 | 5 United Kingdom | 69,574,000,000 | 2023 | -0.43% | -2.13% | View data |
| 19 | 19 Portugal | 6,033,800,000 | 2023 | -2.53% | -4.53% | View data |
| 20 | 20 Norway | 5,951,900,000 | 2023 | +1.05% | -0.35% | View data |
| 21 | 21 Philippines | 5,089,200,000 | 2023 | +3.36% | +4.1% | |
| 22 | 22 Finland | 4,941,000,000 | 2023 | -2.53% | -2.14% | View data |
| 23 | 23 Hungary | 4,389,900,000 | 2023 | -0.26% | +0.75% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
